Correlation of Bcl-2 with P-Glycoprotein Expression in Chronic Lymphocytic Leukaemia and Other Haematological Neoplasms but of Neither Marker with Ex Vivo Chemosensitivity or Patient Survival

References

• McClean S., Hill B. T. An overview of membrane, cytosolic and nuclear proteins associated with the expression of resistance to multiple drugs in vitro. Biochimica Biophysica Acta 1992; 1114: 107–127
   PubMed Web of Science ®Google Scholar
• Tsujimoto Y., Cossman J., Jaffe E., Croce E. M. Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985; 228: 1440–1443
   PubMed Web of Science ®Google Scholar
• Campos L., Rouault J.-P., Sabido O., Oriol P., Roubi N., Vasselon C., Archimbaud E., Magaud J.-P., Guyotat D. High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood 1993; 81: 3091–3096
   PubMed Web of Science ®Google Scholar
• Leoncini L., Del Vecchio M. T., Megha T., Barbini P., Galieni P., Pileri S., Sabattini E., Gherlinzoni F., Tosi P., Kraft R., Cottier H. Correlations between apoptotic and proliferative indices in malignant non-Hodgkin's lymphomas. American Journal of Pathology 1993; 142: 755–763
   PubMed Web of Science ®Google Scholar
• Fruehauf J. P., Bosanquet A. G. In vitro determination of drug response: A discussion of clinical applications. Principles and Practice of Oncology Updates 1993; 7(12)1–16
   Google Scholar
• Bosanquet A. G. Short-term in vitro drug sensitivity tests for cancer chemotherapy. A summary of correlations of test response with both patient response and survival. Forum Trends in Experimental and Clinical Medicine 1994; 4: 179–195
   Google Scholar
• Bosanquet A. G., Bell P. B. Novel ex vivo analysis of nonclassical, pleiotropic drug resistance and collateral sensitivity induced by therapy provides a rationale for treatment strategies in chronic lymphocytic leukemia. Blood 1996; 87: 1962–1971
   PubMed Web of Science ®Google Scholar
• Bosanquet A. G., Bell P. B. Enhanced ex vivo drug sensitivity testing of chronic lymphocytic leukaemia using refined DISC assay methodology. Leukaemia Research 1996; 20: 143–153
   PubMed Web of Science ®Google Scholar
• van Der Valk P., van Kalken C. K., Ketelaars H. J., Broxterman H. J., Scheffer G., Kuiper C. M., Tsuruo T., Lankelma J., Meijer C. J. L. M., Pinedo H. M., Scheper R. J. Distribution of multi-drug resistance-associated P-glycoprotein in normal and neoplastic human tissues. Annals of Oncology 1990; 1: 56–64
   PubMed Web of Science ®Google Scholar
• Georges E., Bradley G., Gariepy J., Ling V. Detection of P-glycoprotein isoforms by gene-specific mono-clonal antibodies. Proceedings of the National Acadamy of Sciences of the United States of America 1990; 87: 152–156
   PubMed Web of Science ®Google Scholar
• Reed J. C., Tsujimoto Y., Alpers J. A., Croce C. M., Nowell P. C. Regulation of bcl-2 proto-oncogene expression during normal human lymphocyte proliferation. Science 1987; 236: 1295–1299
   PubMed Web of Science ®Google Scholar
• Delia D., Aiello A., Soligo D., Fontanella E., Melani C., Pezzella F., Pierotti M. A., Della Porta G. bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells. Blood 1992; 79: 1291–1298
   PubMed Web of Science ®Google Scholar
• Pezzella F., Morrison H., Jones M., Gatter K. C., Lane D., Harris A. L., Mason D. Y. Immunohistochemical detection of p53 and bcl-2 proteins in non-Hodgkin's lymphoma. Histopathology 1993; 22: 39–44
   PubMed Web of Science ®Google Scholar
• El Rouby S., Thomas A., Costin D., Rosenberg C. R., Potmesil M., Silber R., Newcomb E. W. p53 gene mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is independent of MDR MDR3 gene expression. Blood 1993; 82: 3452–3459
   PubMed Web of Science ®Google Scholar
• Haldar S., Beatty C., Tsujimoto Y., Croce C. M. The bcl-2 gene encodes a novel G protein. Nature 1989; 342: 195–198
   PubMed Web of Science ®Google Scholar
• Haldar S., Jena M., Croce C. M. Inactivation of Bcl-2 by phosphorylation. Proceedings of the National Academy of Sciences of the United States of America 1995; 92: 4507–4511
   PubMed Web of Science ®Google Scholar
• Jaattela M., Benedict M., Tewari M., Shayman J. A., Dixit V. M. Bcl-x and Bcl-2 inhibit TNF and Fasinduced apoptosis and activation of phospholipase A2 in breast carcinoma cells. Oncogene 1995; 10: 2297–2305
   PubMed Web of Science ®Google Scholar
• Strosberg A. D. Structure/function relationship of proteins belonging to the family of receptors coupled to GTP-binding proteins. European Journal of Biochemistry 1991; 196: 1–10
   PubMedGoogle Scholar
• Martin S. J., Reutelingsperger C. P., McGahon A. J., Rader J. A., van Schie R. C., LaFace D. M., Green D. R. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. Journal of Experimental Medicine 1995; 182: 1545–1556
   PubMed Web of Science ®Google Scholar
• Haldar S., Beatty C., Croce C. M. BCL-2 alpha encodes a novel small molecular weight GTP binding protein. Advances in Enzyme Regulation 1990; 30: 145–153
   PubMedGoogle Scholar
• Hsu B., Marin M. C., Brisbay S., McConnell K., McDonnell T. J. Expression of bcl-2 gene confers multidrug resistance to chemotherapy-induced cell death. The Cancer Bulletin 1994; 46: 125–129
   Google Scholar
• Oltvai Z. N., Korsmeyer S. J. Checkpoints of dueling dimers foil death wishes. Cell 1994; 79: 189–192
   PubMed Web of Science ®Google Scholar
• Romaguera J. E., Pugh W., Luthra R., Goodacre A., Cabanillas F. The clinical relevance of t(14;18)/BCL-2 rearrangement and DEL 6q in diffuse large cell lymphoma and immunoblastic lymphoma. Annals of Oncology 1993; 4: 51–54
   PubMed Web of Science ®Google Scholar
• List A. F., Spier C., Greer J., Wolff S., Hutter J., Dorr R., Salmon S., Futscher B., Baier M., Dalton W. Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia. Journal of Clinical Oncology 1993; 11: 1652–1660
   PubMed Web of Science ®Google Scholar
• Russo D., Marie J. P., Zhou D. C., Faussat A. M., Melli C., Damiani D., Michelutti A., Michielli M., Fanin R., Baccarani M., Zittoun R. Evaluation of the clinical relevance of the anionic glutathione-S-transferase (GST) and multidrug resistance (mdr-1) gene coexpression in leukemias and lymphomas. Leukaemia and Lymphoma 1994; 15: 453–468
   PubMed Web of Science ®Google Scholar
• Hickman J. A. Apoptosis induced by anticancer drugs. Cancer Metastasis Reviews 1992; 11: 121–139
   PubMed Web of Science ®Google Scholar
• Begleiter A., Lee K., Israels L. G., Mowat M. R. A., Johnston J. B. Chlorambucil induced apoptosis in chronic lymphocytic leukemia (CLL) and its relationship to clinical efficacy. Leukemia 1994; 8: S103–106, Suppl 1)
   PubMed Web of Science ®Google Scholar